Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1.06 Million - $1.29 Million
24,200 New
24,200 $1.06 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $355,352 - $526,750
-8,600 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $47,100 - $60,504
1,200 Added 16.22%
8,600 $370,000
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $265,734 - $301,032
7,400 New
7,400 $290,000
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $610,878 - $872,812
-22,600 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $121,804 - $138,232
3,700 Added 19.58%
22,600 $885,000
Q3 2019

Oct 16, 2019

SELL
$32.49 - $42.13 $74,727 - $96,899
-2,300 Reduced 10.85%
18,900 $679,000
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $783,975 - $880,224
21,200 New
21,200 $861,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Enlightenment Research, LLC Portfolio

Follow Enlightenment Research, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Enlightenment Research, LLC with notifications on news.